Skip to main content

Bioceres Crop Solutions Corp.

corporate_fare Company Profile

Bioceres Crop Solutions Corp.

BIOX·NASDAQ·Industrial Applications And Services·CIK 0001769484

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for BIOX at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Bioceres Subsidiaries' Collateral Foreclosed for $15M Amidst Disputed Defaults

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$238.28M
Net Income
-$263.94M
Diluted EPS
-$4.06
Op. Cash Flow
$66.01M
Free Cash Flow
$64.96M
Gross Profit
$83.18M
Operating Income
-$23.41M
Cash & Equivalents
$7.22M
Total Debt
$59.98M
Debt / Equity
1.76×
Net Margin
-110.8%
Source: 20-F · filed 2026-10-30 · accession 0001104659-26-120726

Insider Transactions

BIOX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$0.175 +1.16% today
52-week range · as of 2026-10-30 $0.175 – $2.1
Market cap
$11.04M
Volume
130.2K (0.6× avg)
3-mo avg 216.3K
Live data · 2026-11-22 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BIOX - Filings & News (Page 2)

BIOX
Jan 20, 2026, 4:02 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $0.175 info
Change: -$1.13 (-87%) info
Market Cap: $11.04M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets